STOCK TITAN

Nasdaq warns Callan JMB (CJMB) on sub-$1 bid price and delisting risk

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Callan JMB Inc. has received a Nasdaq notice that its common stock no longer meets the $1.00 minimum bid price requirement, based on 30 consecutive business days below that level. The stock continues to trade on the Nasdaq Capital Market under the symbol CJMB.

The company has an initial 180-day compliance period, until December 28, 2026, to regain compliance by achieving at least $1.00 per share for a minimum of ten consecutive business days, or longer if Nasdaq requires. If still noncompliant, a second 180-day period may be available, potentially involving a reverse stock split.

If compliance is not regained within the allowed periods, Nasdaq may initiate delisting, which the company could appeal to a Nasdaq Hearings Panel. Callan JMB states it will actively monitor its share price and consider options, including a reverse split, but there is no assurance it will maintain its listing.

Positive

  • None.

Negative

  • None.

Insights

Nasdaq bid-price deficiency creates real delisting risk if not cured.

Callan JMB Inc. has fallen below Nasdaq’s $1.00 minimum bid price standard for 30 consecutive business days. This triggers a formal deficiency notice but does not immediately remove the shares from the Nasdaq Capital Market.

The company has an initial 180-day window to lift the closing bid to at least $1.00 for ten consecutive business days, with Nasdaq able to extend that requirement up to 20 days. A second 180-day period is possible if other listing standards, including market value of publicly held shares, are met.

If the price does not recover, Callan JMB may need structural actions, such as a reverse stock split, to regain compliance. Failure to remedy within the available periods could lead to a delisting determination and appeal before a Nasdaq Hearings Panel, which would materially affect where and how the stock trades.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice or transferred its listing to a different exchange.
Minimum bid price $1.00 per share Nasdaq Listing Rule 5550(a)(2) requirement
Initial compliance period 180 calendar days Until December 28, 2026 to regain bid-price compliance
Bid-price cure window 10–20 business days Closing bid must be at least $1.00 for at least ten consecutive business days
Additional compliance period 180 calendar days Possible second period if other initial listing standards are met
Trading symbol CJMB Common stock continues trading on Nasdaq Capital Market
Minimum Bid Price Requirement regulatory
"the Company no longer satisfies the requirement to maintain a minimum bid price of $1.00 per share"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Listing Rule 5550(a)(2) regulatory
"minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2)"
reverse stock split financial
"its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Nasdaq Hearings Panel regulatory
"the Company may appeal Nasdaq’s determination to a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
forward-looking statements regulatory
"contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0002032545 0002032545 2026-06-29 2026-06-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 29, 2026

 

Callan JMB Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   001-42506   99-0931141

(State or other jurisdiction 

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

244 Flightline Drive

Spring Branch, Texas

  78070
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (830) 438-0395

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   CJMB   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On June 29, 2026, Callan JMB Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer satisfies the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).

The Notice has no immediate effect on the listing of the Company’s common stock, which continues to trade on The Nasdaq Capital Market under the symbol “CJMB.”

 

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial compliance period of 180 calendar days, or until December 28, 2026, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Company’s common stock must be at least $1.00 per share for a minimum of ten consecutive business days during the compliance period, although Nasdaq may, in its discretion, require the Company to maintain a closing bid price of at least $1.00 per share for a period in excess of ten consecutive business days (generally no more than 20 consecutive business days) before determining that the Company has regained compliance.

 

If the Company does not regain compliance with the Minimum Bid Price Requirement by December 28, 2026, the Company may be eligible for an additional compliance period of 180 calendar days. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and would need to notify Nasdaq in writing of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not regain compliance within the applicable compliance period(s), Nasdaq will provide notice that the Company’s common stock will be subject to delisting, at which time the Company may appeal Nasdaq’s determination to a Nasdaq Hearings Panel.

 

The Company intends to actively monitor the closing bid price of its common stock and will consider available options to regain compliance with the Minimum Bid Price Requirement, which may include effecting a reverse stock split. There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement or will otherwise maintain compliance with the other listing requirements of The Nasdaq Capital Market.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or the future financial performance of the Company and involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.

 

In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “projects,” “potential,” “continues,” or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding the Company’s ability to regain compliance with the Minimum Bid Price Requirement during the applicable Nasdaq compliance period(s), the Company’s intention to monitor the closing bid price of its common stock and to consider available options to regain compliance, including the potential implementation of a reverse stock split, and the Company’s ability to maintain compliance with the other listing requirements of The Nasdaq Capital Market.

 

These forward-looking statements reflect the Company’s current expectations and projections based on information available as of the date of this Current Report on Form 8-K and are subject to a number of risks and uncertainties, including, but not limited to, general economic, financial, and business conditions; the Company’s ability to successfully implement its strategic initiatives; supply chain disruptions; regulatory compliance and legal proceedings; and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.

 

The Company cautions investors that forward-looking statements are not guarantees of future performance and actual results may differ materially from those projected. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 2, 2026 Callan JMB Inc.
     
  By: /s/ Wayne Williams
  Name: Wayne Williams
  Title: Chief Executive Officer

 

 

 

 

FAQ

What Nasdaq notice did Callan JMB Inc. (CJMB) receive?

Callan JMB Inc. received a Nasdaq notice that its common stock no longer meets the $1.00 minimum bid price requirement. This follows 30 consecutive business days with a closing bid below $1.00, triggering a formal bid-price deficiency under Nasdaq Listing Rule 5550(a)(2).

Does the Nasdaq notice immediately delist Callan JMB (CJMB) stock?

No, the notice does not immediately delist the stock. Callan JMB’s common shares continue trading on the Nasdaq Capital Market under the symbol CJMB while the company works within defined compliance periods to restore the minimum $1.00 bid price requirement.

How long does Callan JMB (CJMB) have to regain Nasdaq bid-price compliance?

Callan JMB has an initial 180-day period, until December 28, 2026, to regain compliance. The stock’s closing bid must reach at least $1.00 per share for a minimum of ten consecutive business days within this window, or longer if Nasdaq so requires.

What steps might Callan JMB (CJMB) take to meet Nasdaq’s minimum bid price?

The company plans to monitor its closing bid price and consider available options to regain compliance. These options may include effecting a reverse stock split, which would increase the per-share price without changing overall market capitalization.

What happens if Callan JMB (CJMB) cannot meet Nasdaq’s bid-price rule?

If Callan JMB does not regain compliance within the allowed 180-day period, it may qualify for an additional 180-day window if other listing standards are met. Otherwise, Nasdaq can move to delist the stock, and the company could appeal to a Nasdaq Hearings Panel.

Will Callan JMB (CJMB) definitely remain listed on Nasdaq?

There is no assurance the company will maintain its Nasdaq listing. Continued listing depends on regaining compliance with the Minimum Bid Price Requirement within the specified periods and continuing to meet other Nasdaq Capital Market listing standards.

Filing Exhibits & Attachments

3 documents